RAPT Therapeutics, Inc. (RAPT) Retained Earnings (Accumulated Deficit) USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
RAPT Therapeutics, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2018 to 2024.
  • RAPT Therapeutics, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$515 M, a 29.7% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$515 M -$118 M -29.7% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$485 M -$117 M -31.7% Dec 31, 2023 10-Q 2024-05-09
Q3 2023 -$454 M -$109 M -31.6% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$422 M -$98.7 M -30.5% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 -$397 M -$92.6 M -30.4% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$368 M -$83.8 M -29.5% Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$345 M -$78.8 M -29.6% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 -$324 M -$76.2 M -30.8% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 -$305 M -$73.2 M -31.6% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 -$284 M -$69.2 M -32.2% Dec 31, 2021 10-K 2023-03-14
Q3 2021 -$266 M -$64 M -31.7% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 -$247 M -$60 M -32% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 -$231 M -$56.3 M -32.1% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 -$215 M -$52.9 M -32.7% Dec 31, 2020 10-K 2022-03-10
Q3 2020 -$202 M -$53.4 M -35.9% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 -$187 M Jun 30, 2020 10-Q 2020-08-13
Q1 2020 -$175 M Mar 31, 2020 10-Q 2020-05-14
Q4 2019 -$162 M -$43 M -36.1% Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$149 M Sep 30, 2019 10-Q 2019-12-11
Q4 2018 -$119 M Dec 31, 2018 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.